BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32463132)

  • 1. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
    Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
    J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion.
    Zhou Y; Su J; Shi L; Liao Q; Su Q
    Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway.
    Sheng N; Tan G; You W; Chen H; Gong J; Chen D; Zhang H; Wang Z
    Cancer Med; 2017 Jun; 6(6):1331-1340. PubMed ID: 28440035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer.
    Su B; Su J; Zeng Y; Liu F; Xia H; Ma YH; Zhou ZG; Zhang S; Yang BM; Wu YH; Zeng X; Ai XH; Ling H; Jiang H; Su Q
    Oncotarget; 2016 Mar; 7(9):10498-512. PubMed ID: 26871290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-509-3p Induces Apoptosis and Affects the Chemosensitivity of Cervical Cancer Cells by Targeting the RAC1/PAK1/LIMK1/Cofilin Pathway.
    Xu J; Ma X; Yang H; Zhang J; Cai G; Yao N
    Chem Pharm Bull (Tokyo); 2021; 69(4):325-332. PubMed ID: 33790078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1.
    Yu HX; Wang XL; Zhang LN; Zhang J; Zhao W
    Biomed Pharmacother; 2019 Jan; 109():751-761. PubMed ID: 30551528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.
    Tan Y; Hu H; Tan W; Jin L; Liu J; Zhou H
    Mol Med Rep; 2016 Nov; 14(5):4422-4428. PubMed ID: 27665963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho A Regulates Epidermal Growth Factor-Induced Human Osteosarcoma MG63 Cell Migration.
    Wang J; Zhang L; Qu R; Zhang L; Huang W
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of DNA-PKcs gene silencing on proliferation, migration, invasion and apoptosis, and in vivo tumorigenicity of human osteosarcoma MG-63 cells.
    Jin PY; Lu HJ; Tang Y; Fan SH; Zhang ZF; Wang Y; Li XN; Wu DM; Lu J; Zheng YL
    Biomed Pharmacother; 2017 Dec; 96():1324-1334. PubMed ID: 29203385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
    Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
    J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF.
    Ahmed T; Shea K; Masters JR; Jones GE; Wells CM
    Cell Signal; 2008 Jul; 20(7):1320-8. PubMed ID: 18424072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasopharyngeal carcinoma‑associated gene 6 inhibits cell viability, migration, invasion and induces apoptosis in osteosarcoma cells by inactivating the Wnt/β‑catenin signaling pathway.
    Liu L; Wang R; Zhang Z; Wang X
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interfering with pak4 Protein Expression Affects Osteosarcoma Cell Proliferation and Migration.
    Fu Y; Fang L; Yin Q; Wu Q; Sui W; Sun Y; Zhao X; Wu Y; Zhou L
    Biomed Res Int; 2021; 2021():9977001. PubMed ID: 35005025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated migration of human gastric cancer cell via LIMK1.
    Li X; Ke Q; Li Y; Liu F; Zhu G; Li F
    Int J Biochem Cell Biol; 2010 Jan; 42(1):70-9. PubMed ID: 19778628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer.
    Zhao CC; Zhan MN; Liu WT; Jiao Y; Zhang YY; Lei Y; Zhang TT; Zhang CJ; Du YY; Gu KS; Wei W
    Cancer Lett; 2020 Nov; 493():120-127. PubMed ID: 32829006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways.
    Ren T; Zheng B; Huang Y; Wang S; Bao X; Liu K; Guo W
    Cell Death Dis; 2019 Mar; 10(4):261. PubMed ID: 30886151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LIM kinase 1 is required for insulin‑dependent cell growth of osteosarcoma cell lines.
    Zhang HS; Zhao JW; Wang H; Zhang HY; Ji QY; Meng LJ; Xing FJ; Yang ST; Wang Y
    Mol Med Rep; 2014 Jan; 9(1):103-8. PubMed ID: 24247826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.
    Gu Q; Luo Y; Chen C; Jiang D; Huang Q; Wang X
    Exp Cell Res; 2019 Nov; 384(1):111619. PubMed ID: 31525341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
    Yang C; Wu K; Wang S; Wei G
    J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.